Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Soldano

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|April 20, 2010
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytesPaola Montagna, Stefano Soldano, Renata Brizzolara, et al.
Rheumatology International|May 7, 2019
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot studyBarbara Ruaro, Stefano Soldano, Vanessa Smith, et al.
Autoimmunity Reviews|September 10, 2024
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic reviewRosanna Campitiello, Stefano Soldano, Emanuele Gotelli, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatmentMaurizio Cutolo, Barbara Villaggio, Carmen Pizzorni, et al.
RMD Open|December 11, 2025
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo studyVanessa Smith, Stefano Soldano, Rosanna Campitiello, et al.
Annals of the Rheumatic Diseases|July 18, 2018
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosisStefano Soldano, Amelia Chiara Trombetta, Paola Contini, et al.
Respiratory Research|September 26, 2018
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvementAmelia Chiara Trombetta, Stefano Soldano, Paola Contini, et al.
Arthritis Research & Therapy|July 29, 2018
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assayMaurizio Cutolo, Stefano Soldano, Paola Montagna, et al.
Frontiers in Immunology|December 5, 2024
Prevalence of hybrid TLR4<sup>+</sup>M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung diseaseEmanuele Gotelli, Stefano Soldano, Carol Feghali-Bostwick, et al.
Rheumatology (Oxford, England)|July 30, 2020
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro studyMaurizio Cutolo, Stefano Soldano, Paola Montagna, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|April 20, 2010
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytesPaola Montagna, Stefano Soldano, Renata Brizzolara, et al.
Rheumatology International|May 7, 2019
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot studyBarbara Ruaro, Stefano Soldano, Vanessa Smith, et al.
Autoimmunity Reviews|September 10, 2024
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic reviewRosanna Campitiello, Stefano Soldano, Emanuele Gotelli, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatmentMaurizio Cutolo, Barbara Villaggio, Carmen Pizzorni, et al.
RMD Open|December 11, 2025
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo studyVanessa Smith, Stefano Soldano, Rosanna Campitiello, et al.
Annals of the Rheumatic Diseases|July 18, 2018
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosisStefano Soldano, Amelia Chiara Trombetta, Paola Contini, et al.
Respiratory Research|September 26, 2018
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvementAmelia Chiara Trombetta, Stefano Soldano, Paola Contini, et al.
Arthritis Research & Therapy|July 29, 2018
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assayMaurizio Cutolo, Stefano Soldano, Paola Montagna, et al.
Frontiers in Immunology|December 5, 2024
Prevalence of hybrid TLR4<sup>+</sup>M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung diseaseEmanuele Gotelli, Stefano Soldano, Carol Feghali-Bostwick, et al.
Rheumatology (Oxford, England)|July 30, 2020
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro studyMaurizio Cutolo, Stefano Soldano, Paola Montagna, et al.
Pageof 6